Equity
€2.5m ▲ 16.0%
BIOMEDICAL DIAGNOSTICS has made a profit in every financial year since 2006.
BIOMEDICAL DIAGNOSTICS
Lifetime
19 annual accounts with figures on one time axis, 22 filings since 2003peak €2.1m (2008)
€1.3m▼ 4.9%
peak €954,832 (2009)
€339,858▼ 10.1%
peak €2.5m (2025)
€2.5m▲ 16.0%
€1.0m▲ 26.0%
peak 9.2 FTE (2008)
7.4 FTE▲ 10.4%
Board7 names since 2020
2 directors and 1 other
Owners4 names in the annual accounts
consolidates
Documentsfilings and deeds
19-06-202642 days before the deadline
2025abbreviated format
Staff from 6.7 FTE to 7.4 FTEAppointment: (statutory auditor) 26-11New director 02-05Equity from €2.1m to €2.5mDebts from €832,551 to €1.0mInvestments €65,114
Key points
from the 2025 annual accountsInvestments
€72,642 3.0 × depreciation
Green is investment, beige is depreciation. Machinery stands 84.6% higher than in 2024.
Staff
10 employees on 31-12-2025
In 2025, 3 people joined and 1 left.
Filings
22 annual accounts since 2003
The last five annual accounts were filed 31 to 42 days before the end of the period.
At the same address
68 companies
Position in the sector
€2.5m
More equity than 89% of companies in wholesale trade. Sector median €493,293 · 10,732 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,356 companies had the same profile as BIOMEDICAL DIAGNOSTICS has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,356 companies, not a prediction for BIOMEDICAL DIAGNOSTICS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Managing director,
Director, since 27-02-2025
Auditor,
- 100%equity €174,260 (2025) · 2024 annual accounts of BENELUX
- consolidatesannual accounts 2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0479414976
Appointment: (statutory auditor)
General meeting of 17-06-2025 · Gazette deed
New director
appointed, NV Benelux resigned · Permanent representatives: and · Director discharge: NV Benelux · General meeting of 27-02-2025 · Gazette deed
Permanent representative:
Appointment: (managing director) · Board meeting of 13-08-2024 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BIOMEDICAL DIAGNOSTICS Antwerp | €3.5m | €1.3m | 70.2% | 7.4 |
| ROCKMED Rumst | €6.0m | €1.7m | 53.7% | 7.1 |
| DJO BENELUX Geel | €4.0m | €1.1m | 75.0% | 4 |
| F CARE SYSTEMS Antwerp | €3.1m | €1.3m | 52.9% | 11.7 |
| Sakura Finetek Belgium Antwerp | €1.9m | €1.2m | 53.8% | 6.5 |
| TRISTEL Antwerp | €1.9m | €0.9m | 73.3% | 8.3 |
| Immed Benelux Uccle | €2.7m | €1.1m | 50.9% | 6.6 |
These companies have the same main activity as BIOMEDICAL DIAGNOSTICS: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €1.9m and €6m, founded between 1996 and 2007.
Official details
Source: KBO- Status
- Active since 28-01-2003Normal situation
- Registered office
- 70 active companies are registered at this address2 started in the 12 months before. Source: KBO register, as of 12 November 2026.
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Joint committee
- 207White-collar workers in the chemical industry · annual accounts 2025
- Establishment unit
- 2.123.225.7732030 Antwerp, since 25-02-2003
- Financial year end
- 31 December
- Peppol
- Reachable since 21-01-2026
Annual accounts 2025
- ≈ €5.5mestimated
- €3.5m▲ 16.9%
- Employeeson 31-12-2025
- 10▲ 25.0%
- Filing
- Filed on 19-06-2026, 42 days before the end of the filing period
Insights on BIOMEDICAL DIAGNOSTICS
BIOMEDICAL DIAGNOSTICS files the abbreviated format. That format states no turnover. The gross margin fell from €1.4m in 2006 to €1.3m in 2025.
BENELUX holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BIOMEDICAL DIAGNOSTICS
- What is the company number of BIOMEDICAL DIAGNOSTICS?
- The company number of BIOMEDICAL DIAGNOSTICS is 0479.414.976. The VAT number is the same number with BE in front: BE 0479.414.976.
- Where is BIOMEDICAL DIAGNOSTICS based?
- The registered office is at Noorderlaan 139, 2030 Antwerp.Company details
- What does BIOMEDICAL DIAGNOSTICS do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of BIOMEDICAL DIAGNOSTICS?
- BIOMEDICAL DIAGNOSTICS is a public limited company (NV).
- When was BIOMEDICAL DIAGNOSTICS founded?
- BIOMEDICAL DIAGNOSTICS was founded on 28-01-2003.
- Is BIOMEDICAL DIAGNOSTICS still active?
- Yes, BIOMEDICAL DIAGNOSTICS is an active enterprise in the KBO register.
- How many employees does BIOMEDICAL DIAGNOSTICS have?
- BIOMEDICAL DIAGNOSTICS had an average of 7.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does BIOMEDICAL DIAGNOSTICS fall under?
- In its 2025 annual accounts, BIOMEDICAL DIAGNOSTICS states joint committee 207 (White-collar workers in the chemical industry).
- What is the turnover of BIOMEDICAL DIAGNOSTICS?
- The turnover in financial year 2025 is ≈ €5.5m. This figure is estimated from the gross margin of €1.3m and 98 comparable companies (NACE 46). It probably lies between €3.3m and €9.3m.
- Is BIOMEDICAL DIAGNOSTICS profitable?
- In financial year 2025, BIOMEDICAL DIAGNOSTICS made a profit of €339,858.
- Where can I find the annual accounts of BIOMEDICAL DIAGNOSTICS?
- BIOMEDICAL DIAGNOSTICS filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BIOMEDICAL DIAGNOSTICS due?
- BIOMEDICAL DIAGNOSTICS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.